End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
116.1 BDT | -0.43% | -1.36% | -20.59% |
04/03 | Beximco names Iqbal Ahmed as managing director | AN |
30/01 | Beximco Pharmaceuticals to strengthen portfolio as interim profit up | AN |
Sales 2024 * | 44.55B 405M 33.78B | Sales 2025 * | 50.49B 459M 38.28B | Capitalization | 51.79B 471M 39.27B |
---|---|---|---|---|---|
Net income 2024 * | 5.13B 46.67M 3.89B | Net income 2025 * | 6B 54.56M 4.55B | EV / Sales 2024 * | 1.3 x |
Net Debt 2024 * | 5.99B 54.5M 4.54B | Net Debt 2025 * | 884M 8.04M 670M | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
9.44
x | P/E ratio 2025 * |
7.69
x | Employees | 5,700 |
Yield 2024 * |
3.45% | Yield 2025 * |
4.31% | Free-Float | 76.68% |
1 day | -0.43% | ||
1 week | -1.36% | ||
Current month | -0.26% | ||
1 month | +1.49% | ||
3 months | -8.15% | ||
6 months | -20.59% | ||
Current year | -20.59% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 01/90/01 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 01/76/01 | |
Founder | - | 01/76/01 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 01/85/01 |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 116.1 | -0.43% | 144,223 |
24/24/24 | 116.6 | -2.02% | 91,895 |
23/24/23 | 119 | -0.17% | 124,390 |
22/24/22 | 119.2 | +0.25% | 190,856 |
21/24/21 | 118.9 | +1.02% | 150,959 |
End-of-day quote Dhaka S.E., April 25, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 472M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BXPHARMA Stock